U.S. regulators to examine testosterone therapy as use by menopausal women rises

The lack ​of a female-specific product creates practical challenges ‌for clinicians, an approved product could provide standardised dosing, labeling and safety-monitoring guidance and potentially improve insurance coverage

This story was originally reported by The Hindu — Health. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.